Silo Pharma shares are trading higher after the company announced it entered into a Device and CMC Development Master Plan with Resyca BV.
Portfolio Pulse from Benzinga Newsdesk
Silo Pharma shares are trading higher after the company announced it entered into a Device and CMC Development Master Plan with Resyca BV.

July 18, 2024 | 4:05 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Silo Pharma shares are trading higher following the announcement of a Device and CMC Development Master Plan with Resyca BV.
The announcement of a new development plan with Resyca BV is a positive development for Silo Pharma, likely boosting investor confidence and driving the stock price higher in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100